KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 78 filers reported holding KINNATE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,988,000 | -5.2% | 250,000 | 0.0% | 0.06% | -9.2% |
| Q2 2022 | $3,153,000 | -71.6% | 250,000 | -74.6% | 0.06% | -73.8% |
| Q1 2022 | $11,097,000 | -36.5% | 985,568 | 0.0% | 0.25% | -32.2% |
| Q4 2021 | $17,464,000 | -26.2% | 985,568 | -4.2% | 0.37% | -20.8% |
| Q3 2021 | $23,676,000 | -0.3% | 1,028,508 | +0.8% | 0.46% | +9.5% |
| Q2 2021 | $23,746,000 | +120.9% | 1,020,000 | +195.7% | 0.42% | +86.7% |
| Q1 2021 | $10,750,000 | -21.7% | 345,000 | 0.0% | 0.23% | -16.6% |
| Q4 2020 | $13,724,000 | – | 345,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |